VAN VOORHEES SETH (Chief Financial Officer) purchased 40842.5% of their position (16.34K shares) of NRX PHARMACEUTICALS, INC. on the open market
Open‑market purchase worth $18.2K — a major conviction buy. The strongest form of insider conviction signal.
P · 3 purchases
Filed: 11/28/2022ACC: 0001415889-22-011778
Officer· Chief Financial Officer
Since Jun 2022
+16.34K
Net shares
Net buyer
$18.2K
Total acquired
3
Open market trades
3B · 0S
3
Total transactions
16.34K acquired
Non-Derivative Transactions3
Common Stock, par value $0.001 per share
Indirect
Shares
+8.72K
Price / share
$1.12
Trade value
$9.76K
% of position
New position
11/25/2022
0.00→8.72K
Common Stock, par value $0.001 per share
Indirect
Shares
+600.00
Price / share
$1.10
Trade value
$660.00
% of position
6.9%
11/25/2022
8.72K→9.32K
Common Stock, par value $0.001 per share
Indirect
Shares
+7.02K
Price / share
$1.11
Trade value
$7.79K
% of position
75.0%
11/25/2022
9.36K→16.38K
Total
Net shares
+16.34K
Net value
$18.22K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.001 per share Indirect | 11/25/2022 | P · Purchase | +8.72K | $1.12 | $9.76K | New position | 0.00 | 8.72K |
| Common Stock, par value $0.001 per share Indirect | 11/25/2022 | P · Purchase | +600.00 | $1.10 | $660.00 | 6.9% | 8.72K | 9.32K |
| Common Stock, par value $0.001 per share Indirect | 11/25/2022 | P · Purchase | +7.02K | $1.11 | $7.79K | 75.0% | 9.36K | 16.38K |
| Total | +16.34K | $18.22K | ||||||
Derivative Transactions0
No derivative transactions reported